Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

NPF-Approved Content

NPF Endorsed Features
Insurance Delays: Biologic Approvals for Patients With Psoriatic Disease
02/03/2023
Jessica Garlewicz, Digital Managing Editor
A recent review of a university health system’s records showed that “the need for a prior authorization was significantly associated with long waits.”
A recent review of a university health system’s records showed that “the need for a prior authorization was significantly associated with long waits.”
A recent review of a university...
02/03/2023
The Dermatologist
NPF Endorsed Features
The Psoriasis and Comorbidity Series: “Neglected” Comorbidities, Part 3–Malignancy
12/07/2022
Delaney Drew, and Kristi Hawley, DO
In this final installment of a 3-part series on lesser-known comorbidities associated with psoriasis, we explore the connections between psoriasis and malignancy.
In this final installment of a 3-part series on lesser-known comorbidities associated with psoriasis, we explore the connections between psoriasis and malignancy.
In this final installment of a...
12/07/2022
The Dermatologist
NPF Endorsed Features
The Psoriasis and Comorbidity Series: ‘Neglected’ Comorbidities, Part 2—Mental Health
10/18/2022
Delaney Drew, and Kristi Hawley, DO
In this second installment of a 3-part series addressing often overlooked comorbidities of psoriasis, we examine the relationship between psoriasis and mental health disorders.
In this second installment of a 3-part series addressing often overlooked comorbidities of psoriasis, we examine the relationship between psoriasis and mental health disorders.
In this second installment of a...
10/18/2022
The Dermatologist
NPF Endorsed Features
The Psoriasis and Comorbidity Series: ‘Neglected’ Comorbidities, Part 1—Obstructive Sleep Apnea
09/12/2022
Delaney Drew, and Kristi Hawley, DO
In this first installment of a 3-part series on lesser-known comorbidities associated with psoriasis, we focus on a newer, somewhat controversial, association: psoriasis and obstructive sleep apnea, also called obstructive sleep...
In this first installment of a 3-part series on lesser-known comorbidities associated with psoriasis, we focus on a newer, somewhat controversial, association: psoriasis and obstructive sleep apnea, also called obstructive sleep...
In this first installment of a...
09/12/2022
The Dermatologist
NPF Endorsed Features
Psoriatic Disease Clinical Trial Updates
08/16/2022
Riya Gandhi, MA, Associate Editor
Stay up to date with the latest study data on newly approved and potential psoriasis and psoriatic arthritis treatments.
Stay up to date with the latest study data on newly approved and potential psoriasis and psoriatic arthritis treatments.
Stay up to date with the latest...
08/16/2022
The Dermatologist
NPF Endorsed Features
Challenges in PsA Management
06/10/2022
Jessica Bard, Associate Digital Editor, Consultant360
In this exclusive interview, Dr Jeffrey Stark discusses difficulties encountered in the management of patients with psoriatic arthritis.
In this exclusive interview, Dr Jeffrey Stark discusses difficulties encountered in the management of patients with psoriatic arthritis.
In this exclusive interview, Dr...
06/10/2022
The Dermatologist
NPF Endorsed Features
Updates and Insights on Risankizumab for Psoriatic Disease
05/12/2022
Jessica Garlewicz, Associate Digital Editor
Risankizumab-rzaa is the only IL-23 inhibitor approved for adults with moderate to severe plaque psoriasis and active psoriatic arthritis.
Risankizumab-rzaa is the only IL-23 inhibitor approved for adults with moderate to severe plaque psoriasis and active psoriatic arthritis.
Risankizumab-rzaa is the only...
05/12/2022
The Dermatologist
NPF Endorsed Features
Psoriasis Severity: More Than Just a Score Card
03/10/2022
Elizabeth B. Wallace, MD, FAAD
Psoriasis management is moving toward treating the whole patient and not just the psoriasis. Other factors, such as patient quality of life, must be taken into consideration in addition to the disease severity score.
Psoriasis management is moving toward treating the whole patient and not just the psoriasis. Other factors, such as patient quality of life, must be taken into consideration in addition to the disease severity score.
Psoriasis management is moving...
03/10/2022
The Dermatologist
NPF Endorsed Features
Biologics vs Nonbiologics for Treating Psoriasis: Choosing the Right Agent
02/11/2022
Amanda Balbi, Senior Managing Editor, Consultant360
Up to 3% of the US population has psoriasis, and many people are undertreated. Therefore, understanding how to choose the right treatment for psoriasis is important for all health care providers.
Up to 3% of the US population has psoriasis, and many people are undertreated. Therefore, understanding how to choose the right treatment for psoriasis is important for all health care providers.
Up to 3% of the US population...
02/11/2022
The Dermatologist
NPF Endorsed Features
IL-17 and Systemic Inflammation
12/08/2021
Lauren Mateja, Managing Editor
As the science continues to expand, psoriasis is now recognized as a whole-body disease. Understanding IL-17, a key player in systemic inflammation, has led to improvements in treating psoriasis.
As the science continues to expand, psoriasis is now recognized as a whole-body disease. Understanding IL-17, a key player in systemic inflammation, has led to improvements in treating psoriasis.
As the science continues to...
12/08/2021
The Dermatologist

Advertisement

Advertisement

Advertisement

More Psoriasis Content

NPF Endorsed Features
Phone-a-Friend: Exploring the Collaborative Care Model in Psoriasis
08/06/2024
The multifaceted nature of psoriatic disease may require multiple providers from different disciplines or specialties for optimal patient care.
The multifaceted nature of psoriatic disease may require multiple providers from different disciplines or specialties for optimal patient care.
The multifaceted nature of...
08/06/2024
The Dermatologist
Clinical Insights
Nonsteroidal Topical Therapies for Psoriasis and Atopic Dermatitis
06/06/2024
Riya Gandhi, MA, Associate Editor
Treatment regimens for these conditions are evolving as new agents are studied and approved.
Treatment regimens for these conditions are evolving as new agents are studied and approved.
Treatment regimens for these...
06/06/2024
The Dermatologist
merola
Conference Coverage
Psoriasis and Psoriatic Arthritis Treatment: Interleukin Inhibitors
05/08/2024
Riya Gandhi, MA, Associate Editor
During Spring Dermatology Week 2024, Dr Joseph Merola delivered a compelling presentation titled "Enhancing Outcomes for Psoriasis and Psoriatic Arthritis: An Emphasis on Interleukin Inhibitors."
During Spring Dermatology Week 2024, Dr Joseph Merola delivered a compelling presentation titled "Enhancing Outcomes for Psoriasis and Psoriatic Arthritis: An Emphasis on Interleukin Inhibitors."
During Spring Dermatology Week...
05/08/2024
The Dermatologist
NPF Endorsed Features
What’s New in Psoriasis Research
05/03/2024
Riya Gandhi, MA, Associate Editor
Jessica Garlewicz, Digital Managing Editor
Keep up-to-date with this roundup of recent studies.
Keep up-to-date with this roundup of recent studies.
Keep up-to-date with this...
05/03/2024
The Dermatologist
Saakshi-Khattri
Videos
Dual Diagnosing and Managing Psoriasis and Psoriatic Arthritis
04/16/2024

Featuring Saakshi Khattri, MD

Featuring Saakshi Khattri, MD
Explore Dr Khattri's take on the complexities in diagnosing and treating psoriasis and psoriatic arthritis, emphasizing on the need for collaborative decision-making between dermatologists and rheumatologists for optimal patient outcomes.
Explore Dr Khattri's take on the complexities in diagnosing and treating psoriasis and psoriatic arthritis, emphasizing on the need for collaborative decision-making between dermatologists and rheumatologists for optimal patient outcomes.
Explore Dr Khattri's take on the...
04/16/2024
The Dermatologist

Current Issue

August 2024
Volume 32
Issue 5
Current Issue
Issue Archive

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement